Meriam Kabbaj
Chief Tech/Sci/R&D Officer at GENFIT
Profile
Meriam Kabbaj has founded Versantis AG in 2015, where she holds the title of Chief Operating Officer & Director.
She is currently the Chief Technology Officer at Genfit SA since 2022.
Dr. Kabbaj has a doctorate degree from the University of Montréal.
Meriam Kabbaj active positions
Companies | Position | Start |
---|---|---|
GENFIT | Chief Tech/Sci/R&D Officer | 2022-11-30 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Founder | 2014-12-31 |
Training of Meriam Kabbaj
University of Montréal | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
GENFIT | Health Technology |
Private companies | 1 |
---|---|
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Meriam Kabbaj